Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06470711 · ClinicalTrials.gov registry record
Mapping of Electrical Properties in the Brain
A clinical trial of Malignant Glioma, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 120
- Enrollment target
- 1
- Study location
NCT06470711 is a study of Malignant Glioma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 120 participants, above the 89-participant average among 40 other Malignant Glioma trials with a reported enrollment target (35% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06470711, a study of Malignant Glioma, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates imaging methods for monitoring neural and electrical activity in the brain for improving clinical diagnosis.
Conditions Studied
Interventions
- OTHER Non-Interventional Study
Study Locations (1)
Arizona
- Mayo Clinic in Arizona - Scottsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-09-13 |
| Est. Completion | 2027-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06470711
The ClinicalTrials.gov registry entry for NCT06470711 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 89-participant average among 40 other Malignant Glioma trials with a reported enrollment target (35% higher). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Malignant Glioma appearing as the primary indexed condition, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT06470711 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT06470711 about?
NCT06470711 is a clinical study titled "Mapping of Electrical Properties in the Brain". This study evaluates imaging methods for monitoring neural and electrical activity in the brain for improving clinical diagnosis.
What is the current status of trial NCT06470711?
This trial is currently recruiting. The enrollment target is 120 participants. The study started on 2024-09-13. Estimated completion is 2027-09-30.
What conditions does trial NCT06470711 study?
This clinical trial studies the following conditions: Malignant Glioma.
What interventions are being tested in trial NCT06470711?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT06470711?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06470711 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Glioma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CARv3-TEAM-E T Cells in Glioblastoma
RECRUITING · Phase 1
-
Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma
RECRUITING
-
Fitness and Nutrition in Glioma
RECRUITING · NA
-
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
RECRUITING · Phase 1
-
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
RECRUITING · Phase 1
-
Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.